SCHEMBL3959226

SCHEMBL3959226

CNC(=S)NCCCCC(NC(=O)O)c1nc2ccccc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
FPR1 P21462 7/20 0.50
HPGD P15428 1/20 0.49
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
TSHR P16473 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8079286 0.87 HDAC3 (0.70) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL4055523 0.82 BCHE (0.56) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL4058179 0.80 ALDH1A1 (0.62) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5279510 0.78 HDAC3 (0.56) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5483551 0.76 ALDH1A1 (0.66) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5281030 0.76 FPR1 (0.58) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL4049526 0.75 ADORA3 (0.38) HDAC1HDAC6CYP1A2
SCHEMBL3952192 0.74 ALDH1A1 (0.42) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5281920 0.74 TAAR1 (0.50) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5363758 0.73 ALDH1A1 (0.48) ALDH1A1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009026701-A1 SIRTUIN INHIBITORS METHYLGENE INC. (CA) 2009-03-05 WO disclosed